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Summary
Transplantation of untreated F344 rat bone marrow into irradiated B10 mouse recipients (non-
TCD F344 -> B10) to produce fully xenogeneic chimeras resulted in stable xenogeneic lymphoid
chimerism, ranging from 82% to 97% rat . Survival of animals was excellent, without evidence
for GVH disease. The specificity of tolerance which resulted was highly donor-specific ; MHC
disparate third partymouse and rat skin grafts were promptly rejected while donor-specific F344
grafts were significantly prolonged(MST >130 days) . Multi-lineage rat stem cell-derived progeny
including lymphoid cells (T and B-lymphocytes), myeloid cells, erythrocytes, platelets, and natural
killer(NK) cells were present in the fully xenogeneic chimeras up to 7 months after bone marrow
transplantation . Immature rat Tlymphocytes matured and acquired the a/# Tcell receptor in
the thymus of chimeras in a pattern similar to normal rat controls, suggesting that immature
Tlymphocytes ofrat origin could interact with the murine xenogeneic thymic stroma to undergo
normal maturation and differentiation . This model may be useful to study the mechanisms
responsible for the induction and maintenance of donor-specific transplantation tolerance across
a species barrier.
T
echnical advances in solid organ transplantation and the
availability of nonspecific immunosuppressive agents have
revolutionized the field ofsolid organ transplantation . Kidneys,
livers, hearts, lungs, and pancreases arenow transplanted with
excellent results (1-4) . This progress has resulted in a critical
shortage ofessential organs ofsuitable size and match . Many
recipients die while awaiting a lifesaving cardiac or hepatic
transplant for which there is no substitute life support system .
A renewed interest in xenogeneic transplantation has emerged
as one potential solution to the critically short supply ofsolid
organs (5) . However, transplantation of solid organs across
a species barrier has not matched the success of allogeneic
combinations, even for closely related species, because rejec-
tion is vigorous and not prevented by conventionalimmuno-
suppressive agents (5) . Transplantation of T cell depleted
(TCD)1 allogeneic bone marrow following lethal irradiation
has been previously shown to result in stable stem cell en-
graftment and donor-specific transplantation tolerance (10-19) .
Induction oftolerance through transplantation ofbone marrow
1 Abbreviations used in thispaper . CML, cell mediated lympholysis ; MLR,
mixed lymphocyte reaction proliferative assay; MST, medium survival time ;
non-TCD, non-T cell depleted ; RAMB, rabbit anti-mouse brain ; TCD,
T cell depleted.
from one species into another to produce fully xenogeneic
chimerism has been suggested as a possible approach to over-
come these limitations .
It has long beenknown that rat bonemarrow injected into
irradiated mice can significantly prolong survival (6-9) . Con-
gdon and Lorenz (1954) reported that survival of irradiated
recipient mice was prolonged to 21 days following the single
intravenous injection of rat bone marrow cells (6) . Using a
phosphatase stain for leukocytes, Nowell et al . extend this
work to demonstrate that the transplanted bone marrow was
probably functioning hematopoietically as evidenced by rat
leukocyte production (7) . However, longitudinal studies were
limited by poor survival of the chimeras, with most chimeras
surviving less than 4 weeks following reconstitution (6, 7) .
Mice which survived long term had erythrocytes and granu-
locytes of rat origin detectable (7) . Similar findings were
reported by Ford et al . (8), who demonstrated that irradiated
CBA mice reconstituted with Wistar Furth bone marrow
cells had detectable rat cells by chromosomal analysis when
animals were sacrificed at 5, 11, or 19 days (8) . Zaalberg et
al . demonstrated that rat skin grafts of donor type were ac-
cepted in those mice with detectable rat RBC chimerism (9) .
However, studies of these mouse recipients ofrat bone marrow
were limited by the technology available at that time to docu-
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ient mice (6--9) . In all studies, characterization of the specificity
of tolerance induced and multi-lineage productionby ratstem
cells was not preformed . In fact, there is a paucity of data
to indicate whether bone marrow from one species can sur-
vive long term and function normally in the stromal envi-
ronment of another species (5) . Such information is critical
for future progress in transplantation of xenogeneic bone
marrow or solid organs .
We now present evidence for stable rat pluripotent stem
cell engraftment and maturation ofratTlymphocytesin the
xenogeneic stromal environment of normal irradiated B10
mouse recipients after transplantation of untreated rat bone
marrow. The specificity of tolerance in these chimeras was
highly selective: the tolerant recipient did not see RAT as
generic RAT ; instead, the tolerance induced was donorMHC
strain-specific . Fully xenogeneic chimeras exhibited significant
prolongation of donor-strain rat skin grafts with rapid rejec-
tion ofMHC-disparate third-party rat andmouse skin grafts.
This model may be useful to study the mechanism respon-
sible for the induction and maintenance ofdonor-specific trans-
plantation tolerance across a species barrier. In addition, the
kinetics ofengraftmentofthepluripotent stem cell and time-
related regulation of stem-cell-derived lineageproduction in
a xenogeneic environment can be explored .
Materials and Methods
Animals. Six to eight week old male C57BL/10SnJ (B10),
B10.BR, and C3H/HeJ (C3H) mice were purchased from the
Jackson Laboratory, BarHarbor,ME . Four to eightweek old male
Fischer 344 (F344) and Wistar Furth (WF) male rats were pur-
chased from the Harlan SpragueDawley Company. Animals were
housed in a specific pathogen-free facility at the Pittsburgh Cancer
Institute.
Xenogeneic Reconstitutions (Non-TCD F344- B10) or(Non-TCD
WF --. B10). Fully xenogeneically reconstituted animalswere pre-
pared by a modification ofthemethod previously describedfor prep-
aration of mixed allogeneic chimeras (15, 20) . Briefly, inbred
C57BL/1OSn male recipients were lethally irradiated with a single
dose of950Rfrom aCesium source (Nordion) . Using sterile tech-
nique, bone marrow was flushed with Media 199 (Gibco, Grand
Island, New York) containing 50 pl/ml Gentamicin(MEM)from
the femurs and tibias ofmice and rat donors with a22 gauge needle.
Themarrow wasmechanically resuspended in MEMby gentle aspi-
ration through an 18 gauge needle and the suspension filtered
through sterile nylon mesh . The cells were then pelleted at 1000
rpmfor 10 minutes, resuspended, and counted . B10bone marrow
cells were T -cell depleted by treatment with a 1 to 40 dilution of
rabbit anti-mouse-brain (RAMB) in MEM (1 x 108 cells/ml)
(4°C for 30 minutes) plus guinea pig complement (37°C for 30
minutes) (Gibco, Grand Island, NewYork) as previously described
(5, 12) . Cells were washed twice and resuspended in MEM at the
appropriate concentration to allow injection of 1 ml per animal .
Rat bone marrow was untreated . Recipient animals were recon-
stituted within 4 to 6 hours following lethal irradiation via the
lateral tail veins using a #27gauge needle. Fully xenogeneically recon-
stituted animals received 40 x 106 non-TCD F344 (F344 -" B10)
or Wistar Furth (WF - B10) rat bone marrow cells . Mixed
xenogeneically reconstituted animals received 5 x 106 Tcell depleted
bio mouse bone marrow cells plus 40 x 106 non-TCD F344 rat
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bone marrow cells unless otherwise specified. Radiation controls
were prepared to confirm adequacy of the radiation.
Characterization ofChimeras by Flow Cytometry .
￿
Recipients were
characterized for engraftment with syngeneic and/or xenogeneic
donor lymphoid elements using flow cytometry to determine the
percentage o£ peripheral blood lymphocytes (PBL) bearing H-26
andF344 orWF surface markers (15, 20). Briefly, peripheralblood
was collected into heparinized plasticserum vials . After thorough
mixing, the suspension was layered over 3ml ofroom temperature
LSM, (Organon Technica, Kensington, MD) and centrifuged at
23°C (1700rpm x 30 minutes) . The lymphocyte layerwas aspi-
ratedfrom the saline-LSM interface andwashed with medium . Red
blood cells were ACKlysed (ammonium chloride potassium car-
bonate lysing buffer, made in our laboratory) and the remaining
cells stained with various monoclonal antibodies for 30 minutes
at 4°Cand counterstained with sandwich when required . Arbitrary
levels on log scale were selected based on the inflection pointwhere
staining of the control negative population was minimized while
retaining maximal numbers of positive cells.
Analyses of splenic and thymic lymphoid cells were performed
using a Becton-Dickinson Fluorescence Activated Cell Sorter (FACS
II) as previously described (15, 20) . Monoclonal antibodies anti-
WF and anti-F344-Biotin, whichwere generated in rats and gener-
ously supplied by Dr. HeinzW . Kunz, were utilized for Class I
staining of rat cells (21) . Anti-H-21 monoclonal antibody (B22-
249, Rl, Serotec, Bioproducts for Science, Indianapolis, IN) was
initially utilized for staining B10 cells . However, because of cross
reactivity on F344 cells, this was substituted with 28-8-6S (IgG2a)
obtained from ATCC and characterized in our laboratory. Further
subset-specific markers in the rat includingCD4 (W3/25) (Serotec)
(22); CD8 (OX8) (Serotec) (22) ; monocytes, OX41(Serotec) (23) ;
Thy 1.1(Serotec) (24) ; the a/(3 T-cell receptor (TCR), R73 (Serotec)
(25) ; CD5 (Serotec) (26) ; CD3 (27) (generously supplied by Dr.
Yoshiyuki Hasmimoto), and anti-rat NK (3.23 ; generously sup-
plied by Dr. John Hiserodt) (28) were utilized for staining and
lineage-specific analyses. All subset-specificmonoclonal antibodies
were species-specific and non-cross reactive on the irrelevant spe-
cies. Data were displayed as cell frequency histograms in which log
fluorescence intensitywas displayedon the horizontal (x) axis and
relative cell number on the vertical (y) axis.Thepercentage ofcells
considered positive after staining with the relevant monoclonal an-
tibody was calculated using a cut-offfor positivity determined from
the control fluorescence profiles of negative and positive control
populations (B10 mouse and F344 rat) .
Monoclonal Antibodiesfor Staining.
￿
The following monoclonal
antibodies were used FITC-conjugated: CD4, CD8, CD5, R7.3,
Thy 1.1,and3.2.3 . FITC-conjugated Leu4(BectonDickinson and
Company, Mountain View, California) was used as an irrelevant
control for background staining. CD3 is an IgMisotype and anti-
IgM-FITC was used as a sandwich stain .
Skin Grafting.
￿
Skin grafting was performedby a modification
ofthe method ofBillingham andMcJawar as previously described
(14, 21) . Full thickness skin grafts were harvested from the tails
of F344 (RtlA'), and Wistar-Forth (RtlA°) rats and C57BL/lOSn
(H-26) and C3H (H-2k) mice . Mice were anesthetized with
tribromoethanol intraperitoneally (29) and full thickness graft beds
prepared surgically in the lateral thoracic wall . Care was taken to
preserve the panniculus carnosum . The grafts were covered by a
double layer ofvaseline gauzeanda plaster cast to prevent shearing .
If more than one skin graft was placed on an animal, each defect
for graft placement was separated by a 3mm skin bridge . Casts
were removed on the eighth day . Grafts were scored daily for per-
cent rejection, and rejection wasconsidered complete when no re-sidual viable graft could be seen . Chronic rejection was the time
point at which erythema and induration appeared in the grafts.
Graft survivals were calculated by the life-table method (30) and
the median survival time (MST) wasderivedfrom the time point
at which 50% of grafts were surviving.
RedBlood Cell and Platelet Phenotyping: Glucose Phosphate Isomer-
ase-1 Assay (GPI-1). Typing of redblood cell phenotypewas per-
formed by GPI-1 assay (31) . The precipitation pattern for F344 rat
or WF rat and B10 mouse were performed as controls and deter-
mined to be totally disparate. Briefly, 8 jal of RBC were lysed in
400 pl of distilled water, and electrophoresis was performed on
Titan III cellular acetate strips with tris HCl 20 mM glycine 200
mM buffer (pH8.7)(200V for 1 hour). Application was2 cm from
anode . After the run, the strips were covered with a 1% agarose
gel containing tris-HC1100Mm Ph 8.0,NADP 300p.M, glucose-
6-phosphate dehydrogenase 0.5 U/ml, fructose-6-phosphate 50mM,
MTT 5001AM, phenozine methosulphate 200 p.M . As precipita-
tion occurred with the formation offormazan salt, thebands be-
came visible (blue) . The gel wasremoved, the reaction was arrested
by immersing the strips in 5% acetic acid, and the bands were
scanned with aQuick-Scan scanner. Percentages were determined
by comparison with the positive control . Values for each individual
chimera were normalized to 100% . After isolation, platelets were
typed in a similar fashion . 1110 mouse and F344 rat were demon-
strated have different precipitation patterns. This technique is able
to reliably detect as low as2% of contaminating ratRBC artificially
titrated into RBC from normal B10 mice in our hands .
Platelet Isolation.
￿
Wholeblood (0.9 ml) was drawn by cardiac
puncture into a syringe containing 0.1 ml Na3 Citrate, 130 mM,
gently mixed and transferred into a microcentrifuge vial . Theblood
was spun for four seconds at the maximal setting (14,000 rpm)
of an Eppendorfmicrocentrifuge (Beckman #5415) . This setting
was chosen through an optimization strategy in which force and
times were varied as a function of retrieved platelet number. This
duration included the acceleration phase, which is incomplete when
power is curtailed at the four second mark . After this, thesamples
were allowed to slow to a halt without braking . Platelet-rich plasma
was then carefully aspirated with a disposable polyethylene pipette,
avoiding any disturbance of the buffy coat . Triplicate platelet counts
were obtained using a Coulter Model ZB1 counter (Hialeah, FL),
and the average (variation 5%) calculated . Platelets were then
processed as described for the glucosephosphate isomerase-1 assay.
Results
Survival ofFully Xenogeneic Chimeras (NonTCD F344 Rat
--~ B10 Mouse). To characterize the ability to achieve suc-
cessful bonemarrow rescue of lethally irradiated normalB10
recipient mice with F344 ratbone marrow, fullyxenogeneic
chimeras (non-TCD F344 rat -1110 mouse) were prepared.
Survival of animals was excellent; 100% at 50 days and 80%
at 180 days (Fig. 1) . Animals appeared healthy, without ap-
parent wasting, anemia, dermatitis or diarrhea associated with
graft versus host disease (GVHD) . Survival was similar to
that for syngeneically reconstituted mice (1310 --> B10) and
mixed xenogeneically reconstituted mice which received a
mixture of 1110 mouseplus untreated rat bonemarrow (1110
+ nonTCD F344 -+ 1110) (Fig. 1) . Unreconstituted radia-
tion controls died within ten days .
Flow Cytometry Typing ofFully Xenogeneic Chimeras: Evi-
dencefor XenogeneicLymphoid Chimerism .
￿
All recipient mice
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Figure 1.
￿
Life-table survival of fully xenogeneic chimeras (non-TCD
F344 rat-B10mouse) (N = 36) . Syngeneically reconstituted mice (1110
y1310)(N = 10) and mixed xenogeneic chimeras (1110 + non-TCD F344
-~ 1110) (N = 10) which received amixture of syngeneic B10 plus un-
treated F344 rat bonemarrow were prepared as controls. Minimum follow-
up was 77 d . Experimental animals prepared for lineage-specific analysis
by flow cytometrywere not included in survival analyses since sacrifice
of the animals was required .
tested (N = 42) exhibited xenogeneic rat chimerism when
typed for rat peripheral blood lymphocytes (PBL) from one
month to 7 mo post-reconstitution . Table 1 shows typing
data from representative animals 4 months post reconstitu-
tion . Chimerism was stable over time with from 82 to 97%
of total peripheral lymphoid cells of rat derivation, demon-
strating that engraftment of xenogeneic rat lymphoid ele-
ments couldbe successfully achieved inB10mouse recipients .
The sensitivity of this assay was determined by titration ex-
Table 1.
￿
Flow Cytometry Typing ofPBL From Fully
Xenogeneic Chimeras*
Animal Reconstitution Rat
M
1
￿
1
￿
Non-TCD F344 - 1110
￿
76.1
2
￿
80.9
3
￿
83.4
4
￿
77.8
5
￿
91.0
6
￿
84.5
2
￿
7
￿
Non-TCD WF -" B10
￿
88.0
8
￿
79.4
9
￿
92.0
10
￿
86.5
11
￿
81 .3
Normal B10
￿
2 .5
Normal F344
￿
98 .2
Normal WF
￿
99.0
Typing was performed by flow cytometry using anti-H-26 (28-8-6S) and
anti-F344 or anti-WFmAbs . Results are from one representative experi-
ment for animals 4 mo following reconstitution .350
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￿
Representativeflow cytometry histogram PBL typing ofnormal
1110, normal F344, and 4 representative fully xenogeneic chimeras 4 mo
following reconstitution . Anti-1110 (H-2b) and anti-F344-biotin mAbs
were used for one color staining . No crossreactivity occurred with the
anti-F344 antibody on normal B10 lymphoid cells . However, there was
moderate cross-reactivity of staining with the anti-1110 mAb (1122-249)
on normal F344 lymphoid cells . ( . . . . ) isotype-specific fluorescence con-
trol (IgG2a or FITC-conjugatedLeu 4) ; (- - - -) anti-1110 mouse ; (~~)
anti-F344 .
periments in which 0.5% of contaminating rat lymphocytes
could be reliably detected when added to normal B10 lym-
phocyte preparations . A representative flow cytometry typing
experiment is shown in Figure 2. Similar results were ob-
tained in a Wistar Furth (WF) rat --> B10 mouse combina-
tion (Table 1 ; Group 2) and using B10.BR (H-2k) or C3H
(H-2k) as recipients of either WF or F344 bone marrow
(data not shown) .
Specificity of Tolerance to Rat and Mouse in Fully Xenogeneic
Chimeras (non7CD F344 - 1110). To determine the pres-
ence and specificity of transplantation tolerance induced and
to assess competence to recognize and reject third party mouse
and rat grafts, skin grafts from donor (F344 ; Rt1.A t ) and
third party (WF ; Rt1.A°) rat and third party mouse(OH;
H-2k) strains were placed on the fully xenogeneic chimeras
(Fig. 3) . Survival of donor-specific skin grafts was specifically
Cross-Species Bone Marrow Transplantation
prolonged (MST > 130 days), while MHC-disparate third
party mouse and rat grafts were promptly rejected (MST =
10 days and 20 days respectively) with a time course similar
to normal B10 mice. These experiments demonstrate that the
specificity oftolerance to rat was highly donor-strain specific
and that competence to recognize MHC-disparate third party
mouse was preserved in these animals .
Donor-type skin grafts initially appeared soft and healthy
without evidence for rejection . However, skin grafts under-
went a slow chronic rejection with development of progres-
sive erythema and induration with onset from 35 to 45 days,
and then followed a course consistent with prolonged chronic
rejection. The appearance of the grafts was similar to that
reported for mixed xenogeneic chimeras prepared with TCD
rat bone marrow (1110 + TCD F344 -" B10) previously de-
scribed (11, 18), and we predict that eventual disappearance
ofthe graftsmay result . The course is one ofprotracted chronic
skin graft rejection, and no change in level of rat lymphoid
chimerism has been observed (data not shown) .
Rat-Stem-Cell-Derived Lineage Analysis in Fully Xenogeneic
Chimeras.
￿
Fully xenogeneic chimeras (non-TCD F344
1110) were examined by flow cytometry for the presence of
various rat-stem-cell-derived hematolymphopoietic lineages
in splenic lymphoid tissue from 3 wk to 7 mo after reconsti-
tution. Thepresence of all rat stem-cell-derived lineages would
be strong evidence for successful engraftment and differenti-
ation of pluripotent rat hematopoietic stem cells in the
xenogeneic environment of a normal B10 mouse recipient .
In all 15 animals examined, F344 rat B-lymphocytes, Tlymph-
ocytes,NK cells, and monocytes, were demonstrated in the
spleen of chimeras (Figure 4) . The profile of staining was
similar to that for a normal F344 rat (Figure 4) . The propor-
tion of B-lymphocytes ranged from 25-32% of total cells ;
CD5 positive cells from 33 to 41% ; NK cells from 8.1 to
10.5%, and monocytes from 36.5 to 38.5% of total cells ana-
lyzed using the lymphoid/myeloid gate .
Erythrocyte andPlatelet Phenotype in FullyXenogeneic Chimeras.
The presence ofrat erythrocytes was determined in chimeras
using the glucose phosphate isomerase-1 assay (GPI-1) (31),
an enzyme for which we have demonstrated that the elec-
trophoretic pattern of F344 rat and B10 mouse differ. In
artificial titrations performed using isolated RBC, as low as
2% of contaminating rat RBC were detectable when added
to normal B10mouseRBC . The10% error is similar to that
experienced for trypan blue exclusion typing of lymphoid
cells (14, 21) . The proportion of red blood cells of rat origin
present in the fully xenogeneic chimeras ranged from 85.7%
to 100% of totalRBC at 7 months following reconstitution
(Table 2) .
The same assay was performed for phenotyping ofisolated
platelets, which were nearly totally (>95%) of rat origin in
all animals tested at 7 months following reconstitution (N
= 12) (Table 3) .
Flow CytometryAnalyses ofRadioresistant B10 Mouse Splenic
Lymphocytes. Radioresistant syngeneic B10 host cells were
present in the splenic lymphoid tissue of chimeras at levels
from 3 to 18% of total lymphoid cells (Fig . 2) . Further subset-100
NORMAL F344
SKIN GRAFT SURVIVAL :
SPECIFICITY OF TOLERANCE
10 20 30 40 50 60 70 80 90 100 110 120 130
DAYS POST SKIN GRAFT PLACEMENT
Figure 3 .
￿
Survival offull thickness tail skin graftsplaced sixweeks post
reconstitution (non-TCD F344 -+ B10) . Each animal received a donor-
specific F344, MHC-disparate third party rat (WF; Rt1.Au), andMHC-
disparate third party mouse graft (C3H; H-2E) . Survival was calculated
by life tablemethod (30), and grafts were followed for aminimum of50 d .
Grafts were scored daily for evidence of rejection, which was considered
complete when no viable residual could be detected.
specific analyses demonstrated that the majority of these cells
were Thy 1.2+ and CD4+ . Murine CD8+ cells were also
consistently detectable at low levels in the range of 1-5%,
while B-cells,NK cells, and macrophages were not detected
at the level of our 0.5% sensitivity. The nature of these ra-
FULLY
XENOGENEIC
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Figure 4 .
￿
Sample flow cytometry analysis for the presence of rat-derived lymphoid, NK, and myeloid lineages obtained from Splenic lymphoid tissue
from a representative fully xenogeneic chimera 3 mo after reconstitution . Staining was performed in single color analysis with (A) anti-Class I F344
rat; (B) B-lymphocytes (0X6); (C Tlymphocytes (a/0-TCR) ; (D) Natural Killer Cells (3.23) ; and (E) monocytes (0X41) . All antibodies were demon-
strated to be non-cross-reactive on B10 Splenic lymphoid cells. ( . . .) isotype-specific fluorescence control (Leu 4-FITC) ; (--) relevant mAb stain.
These low cytometry analyses were all performed utilizing the lymphoid gate .
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Table 2 .
￿
Typing ofRed Blood Cell Phenotype*
Animal
￿
HCTf
￿
Rat RBC
￿
Mouse RBC
One representative experiment for typing of red blood cell phenotype
two months post-reconstitution by GPI-1 assay.
t Hematocrit .
S (F344- B10) .
dioresistant cells is uncertain, but they were clearly not
sufficient to allow survival of the radiation controls.
Flow Cytometry Analysis ofRat-Derived T Cell Subsets and
Markers Present in Splenic Lymphoid Tissue. The phenotype
of rat-derived Splenic lymphoid T-cell subsets in the fully
xenogeneic chimeras was further characterized using species-
specific monoclonal antibodies against rat Thy 1.1, the rat
ct/0-T-cell receptor, CD3 T-cell receptor complex, and rat T-cell
subset markers including CD4, CD5, and CD8 . Thy 1, a
cell surface antigen present in large amounts on thymocytes
RAT LINEAGES PRESENT IN SPLEEN
T CELLS
￿
NK CELLS
￿
MONOCYTES
ua
FLUORESCENCE INTENSITY
90
80
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90.1
(%)
14.3
9.9
z 60 I Reconstitution n _I Graft
Chimera 35 49 100 0
> 50
H II F344- 810 15 F344
0- 01 F344-~ 810 15 I WF Chimera 4S 32 100 0 rr
40 On eh
0-01 F344-1- 810 15 C3H
0-0 1 NORMAL B10 5 F344 Chimera 5S 40 100 0
0°
19 30 Chimera 6S 43 100 0
Normal B10 Mouse 49 0 100 20
Normal F344 Rat 43 100 0
10and brain tissue of rats and mice, exists in two allelic forms
in the mouse (Thy 1.1 and Thy 1.2) and in only one allelic
form in the rat (Thy 1.1) (25, 26) . B10 mice express only
Thy 1.2 . In mice, Thy 1 is expressed on both matureTlym-
phocytes and immature bone marrow cells (22, 23) . In con-
trast, Thy 1.1 is a marker for only immature lymphocytes
in the rat ; it is present on up to45% ofimmature bonemarrow
cells and on only a minority (<10%) of mature T cells in
peripheral lymphoid tissue of the rat (25, 26) . Thus, analysis
of this marker in fully xenogeniec chimeras allowed us to
assess whether rat-bone-marrow-derived T-cell precursors could
undergo the normal maturational loss ofThy 1.1 in themu-
rine stromal environment . All fully xenogeneic chimeras (N
= 15) analyzed exhibited the normal F344 rat pattern of ma-
ture lymphocyte staining in peripheral lymphoid tissues : pe-
ripheral Tlymphocytes were rat-derived CD3 + , CD4+, or
CD8+, CD5 + , ci/P-Tcell receptor+, and Thy 1.1 negative
or dull (Fig . 5) . This staining pattern is characteristic of that
for mature Tlymphocytes in the normal rat (Fig . 5) .
Phenotype ofRat-DerivedTLymphocytes in Thymus ofFully
Xenogeneic Chimeras. To determine whether ratT cells from
the chimeras were derived from bone marrow precursors or
from contaminating matureT lymphocytes transferred with
the untreated rat bone marrow inoculum, we examined the
thymocytes from chimeras specifically forT cell receptors nor-
mally acquired in the thymus . It has been demonstrated in
mice that T cell maturation and receptor expression are de-
velopmentallyregulated in the thymus during interaction with
host thymic stroma . Acquisition of the T cell receptor com-
plex occurs simultaneously with differentiation from double-
positive (CD4+ , CD8+) to single-positive CD4+ or CD8+
Tcells (32-34) . An analogous maturation process is believed
to occur in the rat (25, 27) . Rat-specificT lymphocyte staining
patterns in the thymic lymphoid tissues of fully xenogeneic
FULLY
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CHIMERA
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W
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￿
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Table 3 .
￿
Phenotype of Platelets in Xenogeneic Chimeras*
(WF- B10 or F344 - B10)
* Phenotype of platelets was determined by GPI-Isomerase assay, an en-
zyme for which B10 mouse and WF rat and F344 rat differ .
This group of animals was typed two months post reconstitution . Lym-
phoid typing was performed by flow cytometry 7 d after platelet typing .
t NT - Not tested .
chimeras were analyzed by flow cytometry analysis for the
pattern ofThy 1.1, a/(3-TCR, CD3, CD4, CD5, and CD8
staining (Fig. 6) . In all (N = 15) animals examined, a staining
CD3
￿
CDs
￿
CD4
￿
Cos
FLUORESCENCE INTENSITY
Figure 5 .
￿
Representative flow cytometry analysis of T cell subsets present in the spleen of a fully xenogeneic chimera and control F344 rat 6 mo
after reconstitution . Single color staining was performed using anti-rat Thy 1 .1, anti-a/0 TCR (R73), anti-CD3, anti-CD5, anti-CD4, and anti-CD8 .
R73 is a mouse anti-rat mAb which has been characterized to detect a rat panTcell surface antigen compatible with the predicted properties of the
cx/OTCR on mature and immature T cells (24) . Anti-CD3 binds to the rat T cell receptor complex (25) . CD5 binds to T cells and some activated
B cells . ( .
￿
) Len 4-FITC control for all antibodies except CD3 which requires an IgM sandwich ; (---) relevant mAb stain .
Group Animal Reconstitution
Rat
platelets
Rat
lymphoid
cells
M (%)
1 1 F344 --+ B10 98.8 90 .9
2 95 85.3
3 100 77 .3
4 100 85 .1
5 100 75.8
6 100 79.9
7 100 NV
8 100 NT
9 99.0 NT
2 1 WF --~ B10 99 .2 86.7
3 Normal B10 mouse 0
Normal WF rat 100
Normal F344 rat 100FULLY
XENOGENEIC
CHIMERA
NORMAL F344
v
0
c
Tiyr 1.1
￿
aip~TCR
￿
CD3
￿
CDs
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pattern identical to that for normal thymic maturation of
rat T-cells was present (Figure 6) . A large proportion ofThy
1.1 positive bright rat Tcells was present in the thymus of
both the normal rat and all fully xenogeneic chimeras, com-
patible with an immature staining pattern . CD3 and a/(_
TCR staining were dull for both the chimeras and the normal
thymus, indicating a predominance of immature rat T lym-
phocytes traversing the thymus of chimeras and the normal
rat thymus. CD4 and CD8 staining patterns were also nearly
identical for the normal rats and the fully xenogeneic chimeras.
Most importantly, a "mature rat" fluorescence pattern for
staining with anti-CD3 was present in the peripheral splenic
lymphoid compartment of the chimeras (Figure 5 and 6),
further supporting the . concept that Tcell maturation was
occurring with acquisition oftheCD3-TCR complex in the
xenogeneic thymic stromal environment of the chimeras.
Most rat-derived T cells in the thymus were phenotypi-
cally immature in staining pattern, expressing double-positivity
with both CD4 and CD8-positive antigenic determinants
when analyzed by flow cytometry (Fig. 7A) . As expected,
double negative (CD4 - and CD8 - ) and single positive
(CD4+ or CD8+) cells were present in low proportions. In
contrast, the majority of rat-derived splenic lymphoid cells
were single-positive CD8 or CD4 (Fig. 7 B) . To determine
that the rat antigenic determinants expressed on the splenic
and thymic cells from chimeras were not picked up and ex-
pressed by mouse cells, double staining using anti-rat and
anti-mouseT cell markers was performed (Fig . 8) . Although
a small percentage of mouse-derived CD4 andCD8 positive
cells were present, theThy 1.2 positive mouse cells were not
positive for rat CD4 or CD8, suggesting that true engraft-
ment of the rat stem cell with rat-derived T cell production
and maturation was present in the fully xenogeneic chimeras .
Discussion
FLUORESCENCE INTENSITY
Figure 6 .
￿
Representative FACS analysis of T cell CD subsets present in the thymus of a fully xenogeneic chimera and control F344 rat . Staining
was performed using anti-rat Thy 1 .1, anti ct/iSTCR, anti-CD3, anti-CD5, anti-CD4, and anti-CD8 mAb as in previous experiments. (
￿
) Leu
4-FITC control ; (--) relevant mAb stain . Animal is the same as that in Fig. 5 .
Cross-species transplantation has been suggested as one
potential solution for the current shortage of solid organs
for transplantation which exists in the clinical setting. How-
ever, conventional nonspecific immunosuppressive agents have
not been effective in controlling rejection in even closely
matched species combinations (5) . The mechanisms respon-
sible for graft rejection in xenogeneic transplantation have
not been well characterized, and may, in fact, differ from that
for allogeneic disparities (35) . It was recently reported that
xenogeneic skin graft rejection is mediated primarily by CD4-
positive lymphocytes (35) . Before xenogeneic transplantation
can be applied clinically, a better understanding ofthe mech-
anisms which mediate xenograft rejection and acceptance is
required .
The preparation of allogeneic chimeras using numerous
approaches has been demonstrated to induce donor-specific
transplantation tolerance (10-19), and it has been suggested
that the induction of xenogeneic chimerism through cross-
species bone marrow transplantation may overcome the vig-
orous rejection which occurs when solid organs are trans-
planted into disparate species. Successful engraftment of rat
bonemarrow intomouse recipients was reported in the 1950's
(6-9) . Production of rat-derived leukocytes and RBC was
demonstrated (6-8), as well as acceptance of donor skin grafts
(9) . However, these studies were limited by poor survival and
the limited technology for typing of recipients. We now re-
port the stable long-term engraftment of rat bone marrow
into irradiated mouse recipients. Multi-lineage production of
bone marrow-derived cells, includingRBC, NK, lymphoid,
myeloid cells, and platelets, persisted up to 7 months following
reconstitution, suggesting engraftment of the rat stem cell
or self-renewing bone marrow progenitor cells . SuccessfulFigure 7 .
￿
(A) Two color flow cytometry typing ofCD4 and CD8 rat staining patterns for rat-derived thymic lymphoid cells at 7 mo following
fully xenogeneic reconstitution . Anti-rat CD8-FITC and CD4-PE were utilized for staining. Leu 4 FITC and Leu-4-PE were the irrelevant controls .
otXCR rat versus rat CD4 staining is also shown. (B) Two color flow cytometry analysis o£CD4 and CD8 staining patterns for rat-derived splenic
lymphoid cells in same animal .
engraftment ofrat bone marrow cells using a number ofMHC
and minor-disparate strain combinations suggests that this
may be a generalizable model for closely related species com-
binations. This model cannow be exploited to study mecha-
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nisms responsible for tolerance induction across a species
barrier.
The specificity of tolerance induced by fully xenogeneic
reconstitution (rat --), mouse) was highly specific for both2 COLOR ANALYSIS OF RAT VS . MOUSE
DETERMINANTS IN SPLEEN
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MHC-disparate third party rat and mouse . (Rat -" mouse)
xenogeneic chimeras did not see rat as generic rat or mouse
as generic mouse, but each as MHC-specific strain since the
chimeras were competent to recognize and reject MHC-
disparate third party rat and mouse skin grafts. Whether this
effect was mediated by rat lymphocytes, mouse lymphocytes,
or both is currently under investigation in our laboratory.
Even after the onset ofchronic rejection in donor skin grafts,
chimerism persisted unchanged . We speculate that this chronic
graft rejection is due to antigens present on skin, but not
the tolerizing lymphoid cells, and is similar to the skin-specific
antigens characterized in an allogeneic model by Boyse and
Old (37) and Steinmuller (38) . Similar findings have been
observed in mixed xenogeneic chimeras (TCD B10 + non-
TCD F344- B10) (manuscript submitted) . Studies are in
progress to evaluate the effector and target cells responsible
for this phenomenon .
We previously reported that stable engraftment ofrat bone
marrow could not be achieved in murine recipientswhen the
marrow inoculum was depleted ofT -lymphocytes (15, 20) .
In contrast, excellent survival resulted in the present studies
when irradiated B10 recipients were reconstituted with un-
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se
RAT CD8-FITC
Figure 8 .
￿
Two color flow cytometry analysis of splenic lymphoid cells from fully xenogeneic chimeras was performed to determine whether the
rat T cell markers present were actually picked up by radioresistant B10 mouse cells . Anti-mouse T cell markers included anti-mouse T cell (Thy
1.2), anti-mouseCD4 (L3T4-FITC), and anti-mouseCD8 (Lyt2-PE) . Two-color staining was performed versus anti-ratCD4 and anti-rat CD8-FITC .
Leu 4-PE and Leu-4 FITC staining were performed as controls .
treated rat bone marrow . The excellent survival of fully
xenogeneic chimeras (nonTCD F344 rat -> mouse) prepared
with untreated rat bone marrow is suggestive that cells in
the rat bone marrow inoculum which express T-cell markers
exerted a facilitatiry effect on engraftment ofrat bone marrow
in murine recipients across a species barrier. Numerous reports
in the literature have demonstrated that T-cells play a critical
role in facilitation of engraftment of allogeneicbonemarrow
in both the clinical setting and in animal models (37) . The
present data suggest that the presence of cells which express
T-cell markers in the xenogeneic rat bone marrow inoculum
may similarly facilitate engraftment of rat bone marrow in
mouse recipients across a species barrier. Rabbit-anti-rat brain
sera (anti-0) was used in the past to perform T-cell depletions
of rat bone marrow (39, 40) . However, sinceThy 1 is present
only on immature rat T-cells, this agent may not be effective
at T-cell depletion . The influence of T-cell depletion of rat
bone marrow on engraftment across a species barrier is difficult
to address because of the lack ofcomplement-fixing anti-rat-
Tcell monoclonal antibodies. Cellular depletions utilizing
immunomagnetic beads allows at best a l log reduction, which
is insufficient compared with the 2 to 31og reductions whichresult with monoclonal antibody plus complement treatment
of splenic lymphoid cells or bone marrow (personal observa-
tion) . Therefore, we can only speculate that engraftment of
rat stem cells may be facilitated by the presence ofcells which
express the theta (0) antigen .
The presence of ratTlymphocytes with an immature
staining pattern in the thymus and mature phenotype in the
periphery was strongly suggestive that rat Tlymphocytes were
not only capable of maturation but also the gene rearrange-
ment required to express the T-cell receptor complex in a
xenogeneic stromal environment of the chimeras. The im-
mature rat staining pattern observed in the thymus of the
fully xenogeneic chimeras strongly suggests that the ac/0-
TCRpositive Tlymphocytes detected in the peripheral lym-
phoid tissues were not derived from mature T-lymphocytes
contaminating the untreated rat bone marrow at the time
of transplantation, but instead from bone marrow-derived
precursors which interacted with the thymic stroma to differen-
tiate in a "normal rat" pattern . Maturation of immature rat
Tlymphocytes in the thymus of xenogeneic chimeras followed
a pattern similar to normal rat, with a high proportion of
immature Thy 1.1 bright double-positive (CD4+, CD8+)
Tcells in the thymus but not in the periphery, and a fairly
high percentage of CD3 and a/(3-TCR dull Tlymphocytes
in the thymus compared with the bright, separate peaks for
CD3 and a/a TCR plus CD4 or CD8 single-positive staining
in the peripheral lymphoid tissue.
The absence of obvious graft versus host disease in fully
xenogeneic chimeras preparedwith untreated rat bonemarrow
in our clean facility raises the question ofwhetherGVH dis-
ease can be induced across a species barrier. The contribution
of GVH-reactivity versus immunoincompetence to the
"wasting disease" and mortality observed in fully allogeneic
chimeras (A - B) prepared using allogeneic strain dispari-
ties has been debated . Zinkernagel (41) and Rayfield and Brent
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